itraconazole has been researched along with Chronic Illness in 105 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (2.86) | 18.7374 |
1990's | 29 (27.62) | 18.2507 |
2000's | 33 (31.43) | 29.6817 |
2010's | 34 (32.38) | 24.3611 |
2020's | 6 (5.71) | 2.80 |
Authors | Studies |
---|---|
Agarwal, R; Aggarwal, AN; Chakrabarti, A; Choudhary, H; Dhooria, S; Garg, M; Muthu, V; Prasad, KT; Sehgal, IS | 1 |
Faizal, B; Joy, N; Salil, A | 1 |
Bosch-Nicolau, P; Burgos, J; Molina, I; Salvador, F; Sánchez-Montalvá, A; Sulleiro, E | 1 |
Apolot, D; Bongomin, F; Katende, A; Kirenga, BJ; Kwizera, R; Teu, A; Worodria, W | 1 |
Samaddar, A; Sharma, A; Shrimali, T | 1 |
Bongomin, F; Denning, DW; Garcez, T | 1 |
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
Akitti, T; Côrtes, JG; Cuzzi, T; Fernandes, NC; Quintella, DC | 1 |
Agarwal, R; Agarwal, S; Gupta, S; Gupta, V; Sahoo, AK; Singh, G; Xess, I | 1 |
Li, R; Wang, R; Wang, X | 1 |
Gomi, T; Horino, T; Kamei, K; Miyagawa, S; Onda, A; Yaguchi, H | 1 |
Bongomin, F; Denning, DW; Harris, C; Hayes, G; Kosmidis, C | 1 |
Ashrafi-Khozani, M; Falahati, M; Farahyar, S; Heidarie-Kohan, F; Majdabadi, N; Mohammadnejad, S; Rahimi-Moghaddam, P; Razavi, T | 1 |
Bassas, J; Bielsa, I; Fernández-Rivas, G; Ferrándiz, C; Jaka, A; Richarz, NA | 1 |
Fujimura, M; Makimura, K; Ogawa, H; Tone, K | 1 |
Agarwal, R; Aggarwal, AN; Chakrabarti, A; Garg, M; Gupta, D; Vishwanath, G | 1 |
Eom, JS; Jeon, K; Jhun, BW; Koh, WJ; Kwon, OJ; Lee, JH; Suh, GY | 1 |
Hishiya, N; Kasahara, K; Maeda, K; Matsumoto, K; Mikasa, K; Morita, K; Nario, K; Ogawa, T; Tsujimoto, K; Uno, K; Yamada, Y | 1 |
de Jesús Fernández-Alonso, A; Flores-Franco, RA; Gómez-Díaz, A | 1 |
Ebenezer, J; Maheswaran, S; Mathews, SS; Rupa, V | 1 |
Dabó, H; Gomes, I; Marinho, A | 1 |
Abbas, MA; Ahmed, SA; Al-Hatmi, AM; de Hoog, GS; Jouvion, G; Kolecka, A; Mahgoub, el S | 1 |
Fischer, G; Lee, A; Nguyen, Y | 1 |
Develoux, M | 1 |
Borish, L; Kennedy, JL; Liu, L; Negri, J; Payne, SC; Steinke, JW | 1 |
Jeon, K; Jhun, BW; Koh, WJ; Lee, H; Lee, SY; Moon, SM; Park, HY | 1 |
Ito, A; Kiyokawa, H; Nakashima, R; Suzuki, Y; Takafuji, S | 1 |
Jakopović, M; Mazuranić, I; Miculinić, N; Plestina, S; Redzepi, G; Samarzija, M; Srdić, D | 1 |
Manohar, A; Nizlan, MN | 1 |
Lal, D; Stankiewicz, JA | 1 |
Concepción, JL; Lanza, G; Márquez, E; Paniz-Mondolfi, AE; Pérez-Alvarez, AM | 1 |
Fujimura, M; Makimura, K; Ogawa, H; Takeuchi, Y | 1 |
Badali, H; Cameo, MI; De Hoog, GS; Najafzadeh, MJ; Revillo, MJ; Rezusta, A; Yus, MC; Zubiri, ML | 1 |
Kato, T; Ohnishi, R; Sano, K; Suzuki, T; Yasuda, S | 1 |
Imamura, Y; Ishimatsu, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Miyazaki, T; Mukae, H; Nagayasu, T; Nakano, K; Sakamoto, N; Seki, M; Tagawa, T; Tsuchiya, T; Yamamoto, K; Yamamoto, Y; Yamasaki, N; Yanagihara, K | 1 |
Ghibaudo, G; Peano, A | 1 |
Kauffman, CA; Smith, JA | 1 |
Addidle, M; Grimwade, K; Kasuga, T; Pynn, J; Skellern, P | 1 |
Cano, LE; Diaz-Granados, LR; Duque, JJ; Lopera, DE; Naranjo, TW; Restrepo, A | 1 |
Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M | 1 |
Joseph, NM; Pradeepkumar, NS | 1 |
Bernabeu-Wittel, J; Conejo-Mir, J; Gómez Gómez, MJ; Lorente-Lavirgen, AI | 1 |
Fujii, H; Hayashi, M; Kaneda, T; Kaneko, M; Karino, T; Kida, Y; Suzuki, Y; Tada, K; Tomii, K; Tomioka, H | 1 |
Di MartinoOrtiz, B; Rodríguez-Masi, M; Rodríguez-Oviedo, ML | 1 |
Das, S; Gupta, N; Jain, S; Malik, JN | 1 |
Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC | 1 |
Meneses-García, A; Morales-de la Luz, R; Mosqueda-Taylor, A; Rivera, LM | 1 |
Anyanwu, EC; Campbell, AW; Vojdani, A | 1 |
Apt, W; Honores, P; López, B; Ortiz, S; Osuna, A; Rojas, A; Sánchez, G; Solari, A; Zulantay, I | 1 |
Brochhagen, HG; Chemnitz, J; Cornely, OA; Hübel, K | 1 |
Krause, M; Moll, C; Röthlin, M; Thurnheer, R | 1 |
Goodman, S; Werle, J | 1 |
Klein, AM; Lafreniere, D; Tiu, C | 1 |
Jiang, ZF; Xu, SY; Zhao, SY | 1 |
Apt, W; Arribada, A; Coronado, X; Gil, LC; Mundaca, K; Osuna, A; Rodríguez, J; Sánchez, G; Solari, A; Zulantay, I | 1 |
Bush, D; Gotoff, R; Llinas, L; Olenginski, TP; Weber, V | 1 |
Brooks, HL; Newell, CK; Steinmetz, RL | 1 |
Verma, SB | 1 |
Denning, DW; Dupont, B; Lode, H; Sambatakou, H | 1 |
Fujii, M; Kato, M; Kawabata, A; Sugino, Y; Yagi, A | 1 |
Blignaut, E; Botes, ME; Nieman, HL | 1 |
Choi, JH; Choi, SM; Lee, DG; Min, WS; Park, SH; Shin, WS; Yoo, JH | 1 |
Homma, S; Izumikawa, K; Kawabata, M; Kishi, K; Miyamoto, A; Ohtsu, Y; Sakamoto, S; Takaya, H; Tsuboi, E; Yoshimura, K | 1 |
Daudia, A; Jones, NS | 1 |
Kaplan, B; Nathansohn, N; Shemer, A; Trau, H | 1 |
Borisov, I; Dimitrov, R; Doganov, N; Iarŭkov, A; Raĭcheva, I; Vasilev, N; Veltova, L | 1 |
Aguilera, X; Apt, P; Apt, W; Arribada, A; Cortés, P; Miranda, C; Pérez, C; Rodríguez, J; Zulantay, I | 1 |
Dubois, AE; Kauffman, HF; Koeter, GH; Latge, JP; Tomee, JF; van der Werf, TS | 1 |
Kanazawa, M; Kawashiro, T; Nakamura, H; Naoki, K; Suzuki, Y; Terashima, T | 1 |
Caras, WE; Pluss, JL | 1 |
Ikeda, Y; Kurasawa, T; Matsuo, H; Matsushita, Y; Nakatani, K; Sato, A; Yamadori, H | 1 |
DeHart, DJ | 1 |
Czaika, V; Hopp, M; Kunzelmann, V; Rossner, D; Schmalreck, A; Sterry, W; Tietz, HJ | 1 |
Hazen, KC; Hughs, E; Kolmer, HL; Platts-Mills, TA; Taketomi, EA; Wilson, BB | 1 |
Nalepa, P; Pajor, A; Sidorowicz, M | 1 |
Kutbi, S; Smith, EL | 1 |
Ferro, TJ; Futerfas, R; Phelps, DT; Saraceno, JL; Schwartz, DB | 1 |
Bruno, R; Calderon, W; Filice, G; Malfitano, A; Parisi, A; Patruno, SF; Sacchi, P | 1 |
Byrd, RP; Ramirez, J; Roy, TM | 1 |
Apt, W; Díaz, E; Sánchez, G; Solari, A; Venegas, J; Zulantay, I | 1 |
Apt, W; Rodríguez, J; Sánchez, G; Venegas, J; Zulantay, I | 1 |
Aguilera, X; Apt, W; Arribada, A; Cortés, P; Juri, D; Miranda, C; Pérez, C; Rodriguez, J; Sánchez, G; Zulantay, I | 1 |
Aznar, C; Carme, B; Clyti, E; Couppie, P; Huerre, M; Lemoine, C; Pradinaud, R; Sainte-Marie, D | 1 |
Ewig, S; Gillissen, A; Layer, G; Schäfer, H; Tasci, S | 1 |
Fukuda, M; Iizuka, T; Kume, H; Mochizuki, M; Murase, S; Shimada, S; Takahashi, K | 1 |
Arrese, JE; Piérard, GE; Piérard-Franchimont, C | 1 |
Darras, A; Demory, JL; Jaggi, F; Mulliez, P; Smith, M | 1 |
Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
Morris, DL | 1 |
Fadl, FA; Faizuddin, M; Hassan, KM | 1 |
Brady, RC; Sommerkamp, TG | 1 |
Colombo, MD; Ghetti, E; Piraccini, BM; Tosti, A | 1 |
Lamey, PJ; Lewis, MA; Samaranyake, LP | 1 |
Merkus, JM; Van Heusden, AM | 2 |
Denning, DW; Dupont, B; Stevens, DA; Tucker, RM | 1 |
Gomez, I; Munera, MI; Naranjo, MS; Restrepo, A; Restrepo, P; Trujillo, M | 1 |
Defaveri, J; Graybill, JR | 1 |
Clayton, YM; Hay, RJ; Midgely, G; Moore, MK | 1 |
Arathoon, EG; Denning, DW; Rinaldi, MG; Stevens, DA; Tucker, RM | 1 |
Dupont, B | 1 |
Cumming, D; Elliott, JA; Milne, LJ | 1 |
Jacquemin, JL; Lacroix, C; Rabot, MH; Rovira, JC; Villard, C | 1 |
Blatchford, N; Cauwenbergh, G; Chwetzoff, E; Daunas, J; De Beule, K; De Doncker, P; Koster, M; Legendre, R | 1 |
11 review(s) available for itraconazole and Chronic Illness
Article | Year |
---|---|
Pulmonary infection due to Acrophialophora fusispora in a patient with underlying mixed connective tissue disease and chronic pulmonary aspergillosis: A case report and review of literature.
Topics: Antifungal Agents; Ascomycota; Chronic Disease; Coinfection; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mixed Connective Tissue Disease; Opportunistic Infections; Pulmonary Aspergillosis | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
Topics: Adult; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Itraconazole; Male; Prospective Studies; Pulmonary Aspergillosis; Radiography, Thoracic; Treatment Outcome | 2013 |
[Mycetoma and their treatment].
Topics: Actinobacteria; Antifungal Agents; Chronic Disease; Humans; Itraconazole; Mycetoma; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Blastomyces; Blastomycosis; Central Nervous System Infections; Chronic Disease; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Radiography; Respiratory Distress Syndrome; Sensitivity and Specificity; Skin Ulcer | 2010 |
Chronic coccidioidomycosis infection of the knee: a case report.
Topics: Antifungal Agents; Arthritis, Infectious; Chronic Disease; Coccidioidomycosis; Humans; Itraconazole; Knee; Male; Middle Aged; Orthopedic Procedures; Recurrence; Reoperation | 2004 |
Advances in management of paranasal sinus aspergillosis.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Chronic Disease; Humans; Itraconazole; Respiratory Hypersensitivity; Sinusitis; Tomography, X-Ray Computed | 2008 |
Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma.
Topics: Adult; Antibodies, Fungal; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Disease Progression; Humans; Immunoglobulin G; Itraconazole; Lung; Lung Diseases, Fungal; Male; Monitoring, Immunologic; Recurrence; Tomography, X-Ray Computed | 1995 |
Chronic necrotizing pulmonary aspergillosis: approach to management.
Topics: Aged; Algorithms; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Necrosis; Pneumonectomy; Prognosis; Risk Factors; Treatment Outcome | 1997 |
Diagnosis and treatment of oral candidosis.
Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Opportunistic Infections | 1991 |
Chronic vulvovaginal candidosis: the role of oral treatment.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Female; Humans; Itraconazole; Ketoconazole; Recurrence | 1990 |
17 trial(s) available for itraconazole and Chronic Illness
Article | Year |
---|---|
Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India.
Topics: Adult; Antifungal Agents; Chronic Disease; Female; Humans; India; Itraconazole; Male; Pulmonary Aspergillosis; Recurrence; Treatment Outcome | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
Topics: Adult; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Itraconazole; Male; Prospective Studies; Pulmonary Aspergillosis; Radiography, Thoracic; Treatment Outcome | 2013 |
Efficacy of itraconazole in the treatment of patients with chronic cough whose sputa yield basidiomycetous fungi-fungus-associated chronic cough (FACC).
Topics: Adult; Aged; Antifungal Agents; Basidiomycota; Bronchodilator Agents; Chronic Disease; Cough; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Expectorants; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Mycoses; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Sputum; Statistics, Nonparametric; Treatment Outcome | 2009 |
[An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Capsules; Chronic Disease; Female; Humans; Injections, Intravenous; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis | 2011 |
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever.
Topics: Adult; Amphotericin B; Antifungal Agents; Case-Control Studies; Chronic Disease; Female; Fever; Hematologic Neoplasms; Humans; Infusions, Intravenous; Itraconazole; Male; Neutropenia | 2006 |
Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
Topics: Adult; Antifungal Agents; Chronic Disease; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Leg; Male; Middle Aged; Nails; Onychomycosis; Prevalence; Treatment Outcome; Venous Insufficiency | 2008 |
[Treatment of chronic human Chagas disease with itraconazole and allopurinol. Preliminary report].
Topics: Adolescent; Adult; Allopurinol; Chagas Disease; Child; Chronic Disease; Drug Resistance; Electrocardiography; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Prognosis; Time Factors | 1994 |
[Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Child; Child, Preschool; Chronic Disease; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Recurrence | 1996 |
Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Chronic Disease; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Follow-Up Studies; Humans; Itraconazole; Meningitis, Cryptococcal | 1997 |
Treatment of chronic Chagas' disease with itraconazole and allopurinol.
Topics: Adolescent; Adult; Allopurinol; Animals; Antibodies, Protozoan; Antifungal Agents; Antimetabolites; Biological Assay; Chagas Cardiomyopathy; Chagas Disease; Child; Chronic Disease; Double-Blind Method; Electrocardiography; Follow-Up Studies; Humans; Insect Vectors; Itraconazole; Middle Aged; Nymph; Triatoma; Trypanosoma cruzi | 1998 |
The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Humans; Itraconazole; Nails; Onychomycosis; Pilot Projects; Trichophyton | 2000 |
Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Itraconazole; Male; Methylprednisolone; Middle Aged; Naphthalenes; Paronychia; Probability; Terbinafine; Treatment Outcome | 2002 |
Itraconazole therapy for chronic coccidioidal meningitis.
Topics: Adolescent; Adult; Aged; Antibodies, Fungal; Antifungal Agents; Chronic Disease; Coccidioidomycosis; Female; Humans; Itraconazole; Ketoconazole; Leukocyte Count; Male; Meningitis; Middle Aged; Multicenter Studies as Topic; Prospective Studies | 1990 |
Itraconazole therapy in aspergillosis: study in 49 patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Encephalitis; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Maxillary Sinusitis; Middle Aged; Recurrence | 1990 |
The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987).
Topics: Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Clinical Trials as Topic; Dermatomycoses; Granuloma; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Necrosis | 1988 |
79 other study(ies) available for itraconazole and Chronic Illness
Article | Year |
---|---|
A prospective study comparing itraconazole alone versus systemic steroids alone as adjuncts to topical steroids in the post-operative management of allergic fungal rhinosinusitis.
Topics: Allergic Fungal Sinusitis; Antifungal Agents; Chronic Disease; Humans; Immunoglobulin E; Itraconazole; Methylprednisolone; Nasal Polyps; Prospective Studies; Quality of Life; Sinusitis | 2023 |
A case report of long treatment with Itraconazole in a patient with chronic Chagas disease.
Topics: Adult; Animals; CD4 Lymphocyte Count; Chagas Disease; Chronic Disease; Female; HIV Infections; Humans; Itraconazole; Tomography, X-Ray Computed; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
Algorithm-aided diagnosis of chronic pulmonary aspergillosis in low- and middle-income countries by use of a lateral flow device.
Topics: Adult; Algorithms; Anti-Retroviral Agents; Antifungal Agents; Antitubercular Agents; Aspergillus; Chronic Disease; Female; HIV Infections; Humans; Immunoglobulin G; Immunoglobulin M; Itraconazole; Poverty; Pulmonary Aspergillosis; Radiography, Thoracic; Tuberculosis, Pulmonary; Uganda | 2020 |
Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillus; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; United Kingdom; Voriconazole; Weight Loss | 2020 |
Sarcoid-like cutaneous lesions in chronic adult paracoccidioidomycosis: report of two cases.
Topics: Antifungal Agents; Chronic Disease; Humans; Itraconazole; Male; Middle Aged; Paracoccidioidomycosis; Sarcoidosis; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Tinea corporis presenting as disseminated verrucous plaques caused by Arthroderma incurvatum in a young Indian boy.
Topics: Antifungal Agents; Arthrodermataceae; Child; Chronic Disease; Drug Therapy, Combination; Humans; India; Itraconazole; Male; Terbinafine; Tinea | 2017 |
Image Gallery: Dermatophytic pseudomycetoma caused by Microsporum canis.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Dermatomycoses; Female; Humans; Itraconazole; Microsporum; Treatment Outcome; Wrist; Young Adult | 2018 |
[A case of histoplasmosis with chronic basilar meningitis diagnosed relatively early].
Topics: Adult; Amphotericin B; Antibodies, Fungal; Antifungal Agents; Biomarkers; Brain Stem; Cerebellum; Chronic Disease; Early Diagnosis; Histoplasma; Histoplasmosis; Humans; Immunocompetence; Itraconazole; Magnetic Resonance Imaging; Male; Meningitis, Fungal; Treatment Outcome; Tuberculosis, Pulmonary | 2018 |
Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Body Weight; Chronic Disease; Female; Humans; Immunoglobulin G; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Quality of Life; Retrospective Studies; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Phenylethyl Alcohol; Vulvovaginitis | 2018 |
First case of chronic cutaneous chromoblastomycosis by Rhinocladiella similis aquired in Europe.
Topics: Antifungal Agents; Ascomycota; Chromoblastomycosis; Chronic Disease; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Treatment Outcome | 2018 |
Central suppressant therapies in unexplained chronic cough patients whose sputum cultures yielded Bjerkandera adusta.
Topics: Adult; Air Pollution, Indoor; Antifungal Agents; Antitussive Agents; Chronic Disease; Coriolaceae; Cough; Drug Interactions; Female; Humans; Hypersensitivity; Itraconazole; Male; Medically Unexplained Symptoms; Middle Aged; Mycoses; Pregabalin; Sensation; Skin Tests; Sputum | 2019 |
Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis.
Topics: Administration, Oral; Aged; Antifungal Agents; Chronic Disease; Female; Humans; Itraconazole; Male; Middle Aged; Mycobacterium Infections; Pulmonary Aspergillosis; Retrospective Studies; Treatment Outcome | 2013 |
Chronic invasive sinus and intracerebral aspergillosis controlled by combination therapy with micafungin and a daily dose of 400 mg itraconazole oral solution.
Topics: Aged; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Chronic Disease; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Micafungin; Paranasal Sinus Diseases; Radiography | 2015 |
Chronic progressive disseminated histoplasmosis in a Mexican cockfighter.
Topics: Antifungal Agents; Chronic Disease; Histoplasmosis; Humans; Itraconazole; Male; Mexico; Middle Aged; Occupational Exposure | 2015 |
Current therapeutic protocols for chronic granulomatous fungal sinusitis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Female; Granuloma; Humans; Itraconazole; Male; Middle Aged; Mycoses; Sinusitis; Treatment Outcome; Voriconazole | 2015 |
Pulmonary Aspergillus Nodule--Still Challenging?
Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Chemical and Drug Induced Liver Injury; Chronic Disease; Diagnosis, Differential; Drug Resistance, Fungal; Drug Substitution; Female; Hemoptysis; Humans; Itraconazole; Lung Neoplasms; Middle Aged; Pulmonary Aspergillosis; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Voriconazole | 2015 |
Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Delayed Diagnosis; Diagnostic Errors; Foot Dermatoses; Humans; Immunohistochemistry; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Radiography; Scedosporium; Subcutaneous Tissue; Sudan; Voriconazole | 2015 |
Chronic pulmonary aspergillosis: help is on the way.
Topics: Antifungal Agents; Chronic Disease; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Practice Guidelines as Topic; Pulmonary Aspergillosis; Voriconazole | 2016 |
Management of chronic vulvovaginal candidiasis: a long term retrospective study.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Female; Fluconazole; Humans; Itraconazole; Maintenance Chemotherapy; Middle Aged; Remission Induction; Retrospective Studies; Time Factors; Young Adult | 2017 |
Failure of itraconazole to prevent T-helper type 2 cell immune deviation: Implications for chronic rhinosinusitis.
Topics: Adolescent; Adult; Cell Differentiation; Cells, Cultured; Chronic Disease; Female; Humans; Immunologic Factors; Itraconazole; Lymphocyte Activation; Male; Middle Aged; Rhinitis; Sinusitis; Th1-Th2 Balance; Th2 Cells; Young Adult | 2016 |
Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Chronic Disease; Female; Humans; Itraconazole; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pulmonary Aspergillosis; Retrospective Studies; Rifabutin | 2017 |
[Case of chronic necrotizing pulmonary aspergillosis successfully treated with a combination of liposomal amphotericin B and itraconazole].
Topics: Amphotericin B; Antifungal Agents; Arthritis, Rheumatoid; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Drug Therapy, Combination; Humans; Itraconazole; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Recombinant factor VIIa in massive haemoptysis associated with chronic necrotising aspergillosis.
Topics: Antifungal Agents; Chronic Disease; Factor VIIa; Hemoptysis; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Recombinant Proteins; Treatment Outcome | 2008 |
Chronic nonhealing ulcer of the right thumb with multiple subcutaneous nodules.
Topics: Antifungal Agents; Carcinoma, Basal Cell; Chronic Disease; Diagnosis, Differential; Humans; Itraconazole; Male; Middle Aged; Skin Neoplasms; Skin Ulcer; Sporotrichosis; Thumb; Treatment Failure; Treatment Outcome | 2008 |
Antifungal treatment and chronic rhinosinusitis.
Topics: Administration, Intranasal; Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Chronic Disease; Humans; Itraconazole; Mycoses; Rhinitis; Sinusitis | 2009 |
Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas' disease.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Chagas Disease; Chronic Disease; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Itraconazole; Male; Middle Aged; Trypanocidal Agents; Trypanosoma cruzi | 2009 |
Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.
Topics: Aged; Antifungal Agents; Ascomycota; Chromoblastomycosis; Chronic Disease; Female; Histocytochemistry; Humans; Itraconazole; Thigh | 2010 |
[Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Pulmonary Aspergillosis | 2009 |
Diffuse alveolar hemorrhage following itraconazole injection.
Topics: Antifungal Agents; Chronic Disease; Hemoperfusion; Hemorrhage; Humans; Injections, Intravenous; Itraconazole; Lung Diseases; Male; Middle Aged; Polymyxin B; Pulmonary Aspergillosis | 2010 |
Chronic monolateral otomycosis in a dog caused by Aspergillus ochraceus.
Topics: Administration, Topical; Animals; Antifungal Agents; Aspergillosis; Aspergillus ochraceus; Chronic Disease; Dogs; Itraconazole; Male; Miconazole; Otitis Externa | 2010 |
Chronic disseminated histoplasmosis with prolonged latency.
Topics: Adrenal Glands; Aged, 80 and over; Chronic Disease; Fatal Outcome; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; Male; Reaction Time | 2010 |
Histopathologic and immunologic effects of the itraconazole treatment in a murine model of chronic pulmonary paracoccidioidomycosis.
Topics: Animals; Antifungal Agents; Chronic Disease; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Histocytochemistry; Itraconazole; Lung; Lung Diseases, Fungal; Mice; Mice, Inbred BALB C; Microscopy; Paracoccidioides; Paracoccidioidomycosis | 2010 |
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Chromoblastomycosis caused by Cladophialophora carrionii in a child from India.
Topics: Antifungal Agents; Arm; Ascomycota; Child; Chromoblastomycosis; Chronic Disease; Histocytochemistry; Humans; India; Itraconazole; Male; Microscopy; Mycology; Naphthalenes; Terbinafine; Treatment Outcome | 2011 |
[Erythematous exudative plaque in an elbow for 1 year].
Topics: Aged; Antifungal Agents; Chronic Disease; Elbow; Elbow Injuries; Erythema; Humans; Itraconazole; Male; Sporothrix; Sporotrichosis; Wound Infection | 2012 |
Chronic multifocal paracoccidioidomycosis in an immunocompetent adult.
Topics: Antifungal Agents; Chronic Disease; Facial Dermatoses; Foot Dermatoses; Hand Dermatoses; Humans; Immunocompetence; Itraconazole; Lip Diseases; Male; Middle Aged; Paracoccidioides; Paracoccidioidomycosis; Paraguay; Skin Ulcer | 2012 |
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Paracoccidioidomycosis: report of 2 cases mimicking squamous cell carcinoma.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; Chronic Disease; Diagnosis, Differential; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Mexico; Middle Aged; Mouth Diseases; Paracoccidioidomycosis | 2002 |
Combination of high-dose intravenous immunoglobulins and itraconozole in treating chronic mycotic demyelinating optic neuritis.
Topics: Adult; Antifungal Agents; Autoantibodies; Chronic Disease; Demyelinating Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Environmental Exposure; Evoked Potentials, Visual; Female; Fungi; Humans; Immunoglobulins, Intravenous; Itraconazole; Mycotoxins; Optic Neuritis | 2003 |
Use of polymerase chain reaction (PCR) and hybridization assays to detect Trypanosoma cruzi in chronic chagasic patients treated with itraconazole or allopurinol.
Topics: Adult; Allopurinol; Animals; Antiprotozoal Agents; Chagas Disease; Chronic Disease; Female; Humans; Itraconazole; Male; Nucleic Acid Hybridization; Polymerase Chain Reaction; Trypanosoma cruzi | 2004 |
Successful treatment of chronic disseminated candidiasis with caspofungin and itraconazole in a patient with progressive acute leukemia and prolonged neutropenia.
Topics: Adult; Antifungal Agents; Candidiasis; Caspofungin; Chronic Disease; Echinocandins; Female; Humans; Interleukin-2; Itraconazole; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Opportunistic Infections; Peptides; Peptides, Cyclic; Treatment Outcome | 2004 |
Chronic necrotizing pulmonary aspergillosis complicated by pneumothorax.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Humans; Itraconazole; Lung; Male; Middle Aged; Necrosis; Pneumothorax; Thoracic Surgery, Video-Assisted; Treatment Outcome | 2004 |
Malignant mimickers: chronic bacterial and fungal infections of the larynx.
Topics: Adult; Antifungal Agents; Botrytis; Carcinoma, Squamous Cell; Chronic Disease; Diagnosis, Differential; Histoplasmosis; Humans; Itraconazole; Laryngeal Diseases; Male; Mycoses; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
[Diagnosis and treatment of chronic pulmonary aspergillosis in 4 children].
Topics: Amphotericin B; Child; Child, Preschool; Chronic Disease; Drug Therapy, Combination; Female; Humans; Infant; Itraconazole; Male; Pulmonary Aspergillosis | 2005 |
Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment.
Topics: Adult; Allopurinol; Animals; Arrhythmias, Cardiac; Chagas Disease; Chronic Disease; DNA, Protozoan; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Polymerase Chain Reaction; Trypanosoma cruzi; Xenodiagnosis | 2005 |
Osteomyelitis resulting from chronic filamentous fungus olecranon bursitis.
Topics: Antifungal Agents; Bursitis; Chronic Disease; Elbow Joint; Female; Humans; Itraconazole; Middle Aged; Mycoses; Osteomyelitis | 2005 |
Chronic postoperative endophthalmitis caused by Bipolaris australiensis.
Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Cataract Extraction; Chronic Disease; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Itraconazole; Lenses, Intraocular; Mycoses; Postoperative Complications; Vitrectomy | 2006 |
Chronic disseminated cutaneous histoplasmosis in an immunocompetent individual--a case report.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Dermatomycoses; Diagnosis, Differential; Edema; Female; Histoplasmosis; Humans; Itraconazole; Middle Aged; Tomography, X-Ray Computed; Ultrasonography | 2006 |
[Micafungin therapy for a case of chronic necrotizing pulmonary aspergillosis].
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Therapy, Combination; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Necrosis; Peptides, Cyclic | 2006 |
The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Chemoprevention; Chronic Disease; Cohort Studies; Comprehensive Health Care; Female; Fluconazole; Follow-Up Studies; Heterosexuality; Humans; Itraconazole; Male; Miconazole; Middle Aged; Nystatin; Population Surveillance; Retrospective Studies; South Africa; Treatment Outcome | 1999 |
Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Peptides, Cyclic; Radiography; Retrospective Studies; Treatment Outcome | 2007 |
[The treatment of vulvovaginal candidomycosis with itraconazole (Sporanox)].
Topics: Acute Disease; Administration, Oral; Candida; Candidiasis, Vulvovaginal; Chronic Disease; Drug Evaluation; Female; Humans; Itraconazole; Recurrence | 1994 |
[A case of chronic necrotizing pulmonary aspergillosis treated with itraconazole].
Topics: Administration, Oral; Aged; Aged, 80 and over; Aspergillosis; Chronic Disease; Female; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Necrosis; Tuberculosis, Pulmonary | 1993 |
Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy.
Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Humans; Itraconazole; Male; Middle Aged; Necrosis | 1996 |
[Chronic necrotizing pulmonary aspergillosis treated with itraconazole and inhaled amphotericin B].
Topics: Administration, Inhalation; Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Therapy, Combination; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Necrosis; Tuberculosis, Pulmonary | 1995 |
Use of itraconazole for treatment of sporotrichosis involving a knee prosthesis.
Topics: Antifungal Agents; Arthritis, Infectious; Arthroplasty; Chronic Disease; Humans; Itraconazole; Knee Prosthesis; Male; Microbial Sensitivity Tests; Middle Aged; Prosthesis-Related Infections; Sporothrix; Sporotrichosis; Synovial Fluid | 1995 |
Effect of combined antibacterial and antifungal treatment in severe atopic dermatitis.
Topics: Adult; Allergens; Animals; Anti-Bacterial Agents; Antifungal Agents; Chronic Disease; Dermatitis, Atopic; Drug Therapy, Combination; Eosinophilia; Female; Humans; Itraconazole; Male; Middle Aged | 1996 |
[Chronic semi-invasive aspergillosis with broncho-pleural fistula treated with itraconazole and surgically].
Topics: Antifungal Agents; Aspergillosis; Bronchial Diseases; Chronic Disease; Fistula; Humans; Itraconazole; Male; Middle Aged; Pleural Diseases | 1996 |
Improvement of eumycetoma with itraconazole.
Topics: Chronic Disease; Combined Modality Therapy; Drainage; Follow-Up Studies; Humans; Itraconazole; Mycetoma; Treatment Outcome | 1997 |
Chronic cavitary pulmonary sporotrichosis: efficacy of oral itraconazole.
Topics: Administration, Oral; Antibodies, Fungal; Antifungal Agents; Chronic Disease; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Sporothrix; Sporotrichosis; Tomography, X-Ray Computed | 1998 |
Effect of itraconazole on lytic antibodies levels in chronic Chagas disease.
Topics: Adult; Antibodies, Protozoan; Antifungal Agents; Chagas Disease; Child; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Itraconazole; Middle Aged | 1997 |
[Serologic evaluation of treatment of chronic Chagas disease with allopurinol and itraconazole].
Topics: Adolescent; Adult; Allopurinol; Antiprotozoal Agents; Chagas Disease; Child; Chronic Disease; Follow-Up Studies; Humans; Itraconazole; Middle Aged | 1998 |
[Disseminated histoplasmosis detected by lingual and tonsillar erosions in an immunocompetent patient].
Topics: Alcoholism; Antifungal Agents; Carcinoma, Squamous Cell; Chronic Disease; Diagnosis, Differential; Histoplasmosis; Humans; Immunocompetence; Itraconazole; Male; Middle Aged; Palatine Tonsil; Smoking; Tongue Diseases; Tongue Neoplasms; Tuberculosis, Pulmonary | 1999 |
[Successful treatment of chronic necrotizing pulmonary aspergillosis with oral itraconazole long-term therapy].
Topics: Administration, Oral; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Humans; Itraconazole; Long-Term Care; Lung Diseases, Fungal; Male; Tomography, X-Ray Computed | 1999 |
Serum itraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Digoxin; Drug Interactions; Humans; Itraconazole; Male; Meningitis, Fungal; Serum Albumin | 2000 |
[Pulmonary aspergillosis complicating chronic septic granulomatosis. Treatment with itraconazole and gamma interferon].
Topics: Adult; Antifungal Agents; Aspergillosis; Chronic Disease; Cost-Benefit Analysis; Drug Costs; Granuloma; Humans; Interferon-gamma; Itraconazole; Lung Diseases, Fungal; Male; Prognosis; Sepsis; Treatment Outcome | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
Chronic rhinosinusitis.
Topics: Antifungal Agents; Chronic Disease; Drug Administration Schedule; False Positive Reactions; Fungi; Humans; Itraconazole; Mycoses; Rhinitis; Sinusitis | 2001 |
Allergic fungal rhinosinusitis: report of 4 cases from Saudi Arabia.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Biopsy; Chronic Disease; Combined Modality Therapy; Debridement; Diagnosis, Differential; Female; Humans; Itraconazole; Male; Rhinitis, Allergic, Perennial; Saudi Arabia; Sinusitis; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
Thorn-induced Alternaria flexor tenosynovitis of the hand.
Topics: Alternaria; Antifungal Agents; Child; Chronic Disease; Diagnosis, Differential; Finger Injuries; Humans; Itraconazole; Male; Synovial Membrane; Tenosynovitis; Wounds, Penetrating | 2001 |
Chronic recurrent vaginal candidosis: easy to treat, difficult to cure. Results of intermittent treatment with a new oral antifungant.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Menstrual Cycle; Middle Aged; Recurrence | 1990 |
Treatment of paracoccidioidomycosis with itraconazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Child; Chronic Disease; Humans; Itraconazole; Ketoconazole; Lung; Male; Middle Aged; Paracoccidioidomycosis; Radiography | 1990 |
Treatment of chronic murine chromoblastomycosis with the triazole SCH39304.
Topics: Animals; Antifungal Agents; Chromoblastomycosis; Chronic Disease; Disease Models, Animal; Female; Itraconazole; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron; Mitosporic Fungi; Skin; Triazoles | 1990 |
Itraconazole in the management of chronic dermatophytosis.
Topics: Adult; Aged; Antifungal Agents; Chronic Disease; Dermatomycoses; Drug Administration Schedule; Female; Fingers; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Toes | 1990 |
Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chronic Disease; Coccidioides; Coccidioidomycosis; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence | 1990 |
Chronic necrotising pulmonary aspergillosis treated with itraconazole.
Topics: Antifungal Agents; Aspergillosis; Chronic Disease; Humans; Itraconazole; Ketoconazole; Lung; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Spondylitis, Ankylosing | 1989 |
[Severe Aspergillus keratomycosis treated with itraconazole per os].
Topics: Administration, Oral; Adult; Anterior Chamber; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Corneal Diseases; Humans; Itraconazole; Ketoconazole; Male | 1989 |